312 related articles for article (PubMed ID: 28346496)
21. The impact of SETBP1 mutations in neurological diseases and cancer.
Kohyanagi N; Ohama T
Genes Cells; 2023 Sep; 28(9):629-641. PubMed ID: 37489294
[TBL] [Abstract][Full Text] [Related]
22. PIGF deficiency causes a phenotype overlapping with DOORS syndrome.
Salian S; Benkerroum H; Nguyen TTM; Nampoothiri S; Kinoshita T; Félix TM; Stewart F; Sisodiya SM; Murakami Y; Campeau PM
Hum Genet; 2021 Jun; 140(6):879-884. PubMed ID: 33386993
[TBL] [Abstract][Full Text] [Related]
23. Recommendations for Cancer Surveillance in Individuals with RASopathies and Other Rare Genetic Conditions with Increased Cancer Risk.
Villani A; Greer MC; Kalish JM; Nakagawara A; Nathanson KL; Pajtler KW; Pfister SM; Walsh MF; Wasserman JD; Zelley K; Kratz CP
Clin Cancer Res; 2017 Jun; 23(12):e83-e90. PubMed ID: 28620009
[TBL] [Abstract][Full Text] [Related]
24. Cell-type-specific gene expression and regulation in the cerebral cortex and kidney of atypical Setbp1
Whitlock JH; Soelter TM; Howton TC; Wilk EJ; Oza VH; Lasseigne BN
J Cell Mol Med; 2023 Nov; 27(22):3565-3577. PubMed ID: 37872881
[TBL] [Abstract][Full Text] [Related]
25. 'Splitting versus lumping': Temple-Baraitser and Zimmermann-Laband Syndromes.
Bramswig NC; Ockeloen CW; Czeschik JC; van Essen AJ; Pfundt R; Smeitink J; Poll-The BT; Engels H; Strom TM; Wieczorek D; Kleefstra T; Lüdecke HJ
Hum Genet; 2015 Oct; 134(10):1089-97. PubMed ID: 26264464
[TBL] [Abstract][Full Text] [Related]
26. Somatic SETBP1 mutations in myeloid malignancies.
Makishima H; Yoshida K; Nguyen N; Przychodzen B; Sanada M; Okuno Y; Ng KP; Gudmundsson KO; Vishwakarma BA; Jerez A; Gomez-Segui I; Takahashi M; Shiraishi Y; Nagata Y; Guinta K; Mori H; Sekeres MA; Chiba K; Tanaka H; Muramatsu H; Sakaguchi H; Paquette RL; McDevitt MA; Kojima S; Saunthararajah Y; Miyano S; Shih LY; Du Y; Ogawa S; Maciejewski JP
Nat Genet; 2013 Aug; 45(8):942-6. PubMed ID: 23832012
[TBL] [Abstract][Full Text] [Related]
27. Syndromic disorders caused by gain-of-function variants in KCNH1, KCNK4, and KCNN3-a subgroup of K
Gripp KW; Smithson SF; Scurr IJ; Baptista J; Majumdar A; Pierre G; Williams M; Henderson LB; Wentzensen IM; McLaughlin H; Leeuwen L; Simon MEH; van Binsbergen E; Dinulos MBP; Kaplan JD; McRae A; Superti-Furga A; Good JM; Kutsche K
Eur J Hum Genet; 2021 Sep; 29(9):1384-1395. PubMed ID: 33594261
[TBL] [Abstract][Full Text] [Related]
28. SMARCA4 inactivating mutations cause concomitant Coffin-Siris syndrome, microphthalmia and small-cell carcinoma of the ovary hypercalcaemic type.
Errichiello E; Mustafa N; Vetro A; Notarangelo LD; de Jonge H; Rinaldi B; Vergani D; Giglio SR; Morbini P; Zuffardi O
J Pathol; 2017 Sep; 243(1):9-15. PubMed ID: 28608987
[TBL] [Abstract][Full Text] [Related]
29. "Electrifying dysmorphology": Potassium channelopathies causing dysmorphic syndromes.
Hamilton MJ; Suri M
Adv Genet; 2020; 105():137-174. PubMed ID: 32560786
[TBL] [Abstract][Full Text] [Related]
30. Refractory sacrococcygeal germ cell tumor in Schinzel-Giedion syndrome.
Kishimoto K; Kobayashi R; Yonemaru N; Yamamoto H; Tsujioka T; Sano H; Suzuki D; Yasuda K; Suzuki M; Ando A; Tonoki H; Iizuka S; Uetake K; Kobayashi K
J Pediatr Hematol Oncol; 2015 May; 37(4):e238-41. PubMed ID: 25171454
[TBL] [Abstract][Full Text] [Related]
31. High Yield of Pathogenic Germline Mutations Causative or Likely Causative of the Cancer Phenotype in Selected Children with Cancer.
Diets IJ; Waanders E; Ligtenberg MJ; van Bladel DAG; Kamping EJ; Hoogerbrugge PM; Hopman S; Olderode-Berends MJ; Gerkes EH; Koolen DA; Marcelis C; Santen GW; van Belzen MJ; Mordaunt D; McGregor L; Thompson E; Kattamis A; Pastorczak A; Mlynarski W; Ilencikova D; van Silfhout AV; Gardeitchik T; de Bont ES; Loeffen J; Wagner A; Mensenkamp AR; Kuiper RP; Hoogerbrugge N; Jongmans MC
Clin Cancer Res; 2018 Apr; 24(7):1594-1603. PubMed ID: 29351919
[No Abstract] [Full Text] [Related]
32. [A phenotypic description of 26 patients with Ritscher-Schinzel syndrome (cranio-cerebello-cardiac dysplasia or 3C syndrome)].
Pira-Paredes SM; Montoya-Villada JH; Franco-Restrepo JL; Moncada-Velez M; Cornejo JW
Rev Neurol; 2017 Jun; 64(11):481-488. PubMed ID: 28555453
[TBL] [Abstract][Full Text] [Related]
33. 372 kb microdeletion in 18q12.3 causing SETBP1 haploinsufficiency associated with mild mental retardation and expressive speech impairment.
Marseglia G; Scordo MR; Pescucci C; Nannetti G; Biagini E; Scandurra V; Gerundino F; Magi A; Benelli M; Torricelli F
Eur J Med Genet; 2012 Mar; 55(3):216-21. PubMed ID: 22333924
[TBL] [Abstract][Full Text] [Related]
34. Applications of next-generation whole exome sequencing.
Harding KE; Robertson NP
J Neurol; 2014 Jun; 261(6):1244-6. PubMed ID: 24838538
[No Abstract] [Full Text] [Related]
35. The genetic basis of DOORS syndrome: an exome-sequencing study.
Campeau PM; Kasperaviciute D; Lu JT; Burrage LC; Kim C; Hori M; Powell BR; Stewart F; Félix TM; van den Ende J; Wisniewska M; Kayserili H; Rump P; Nampoothiri S; Aftimos S; Mey A; Nair LD; Begleiter ML; De Bie I; Meenakshi G; Murray ML; Repetto GM; Golabi M; Blair E; Male A; Giuliano F; Kariminejad A; Newman WG; Bhaskar SS; Dickerson JE; Kerr B; Banka S; Giltay JC; Wieczorek D; Tostevin A; Wiszniewska J; Cheung SW; Hennekam RC; Gibbs RA; Lee BH; Sisodiya SM
Lancet Neurol; 2014 Jan; 13(1):44-58. PubMed ID: 24291220
[TBL] [Abstract][Full Text] [Related]
36. Prenatal diagnosis and molecular cytogenetic characterization of an inherited microdeletion of 18q12.3 encompassing SETBP1.
Zhou Y; Quan Y; Wu Y; Zhang Y
J Int Med Res; 2022 Sep; 50(9):3000605221121955. PubMed ID: 36113068
[TBL] [Abstract][Full Text] [Related]
37. Identification of
Leonardi E; Bettella E; Pelizza MF; Aspromonte MC; Polli R; Boniver C; Sartori S; Milani D; Murgia A
Front Neurol; 2020; 11():593446. PubMed ID: 33391157
[No Abstract] [Full Text] [Related]
38. Phenotype-genotype complexities: opening DOORS.
Berkovic SF; Gecz J
Lancet Neurol; 2014 Jan; 13(1):24-5. PubMed ID: 24291219
[No Abstract] [Full Text] [Related]
39. The spectrum of DNMT3A variants in Tatton-Brown-Rahman syndrome overlaps with that in hematologic malignancies.
Shen W; Heeley JM; Carlston CM; Acuna-Hidalgo R; Nillesen WM; Dent KM; Douglas GV; Levine KL; Bayrak-Toydemir P; Marcelis CL; Shinawi M; Carey JC
Am J Med Genet A; 2017 Nov; 173(11):3022-3028. PubMed ID: 28941052
[TBL] [Abstract][Full Text] [Related]
40. DOORS syndrome: phenotype, genotype and comparison with Coffin-Siris syndrome.
Campeau PM; Hennekam RC;
Am J Med Genet C Semin Med Genet; 2014 Sep; 166C(3):327-32. PubMed ID: 25169651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
